Investigator Agreement For Device Studies Template for England and Wales

When you're conducting clinical investigations of medical devices in England and Wales, you need a comprehensive legal framework that protects all parties and ensures regulatory compliance. The Investigator Agreement For Device Studies serves as this critical foundation, establishing clear responsibilities between sponsors, principal investigators, and institutions while adhering to strict UK regulatory requirements.

When do you need this document?

You'll require this agreement whenever conducting any clinical investigation involving medical devices in England and Wales. This includes first-in-human device studies, pivotal clinical trials for CE marking, post-market surveillance studies, and investigator-initiated research involving medical devices. The agreement is essential when academic institutions collaborate with commercial sponsors, when conducting multi-site device studies across NHS trusts, or when investigating novel medical technologies requiring regulatory approval. You'll also need this document for device modification studies where existing products are being tested for new indications or patient populations.

Key legal considerations

Several critical legal elements must be addressed in your agreement. Device handling provisions must specify storage conditions, accountability procedures, and return protocols to ensure compliance with MHRA guidance. Data ownership and intellectual property clauses require careful attention, particularly regarding study results and any innovations discovered during the investigation. Confidentiality provisions must protect proprietary device information while allowing necessary regulatory disclosures. Liability and indemnification clauses should clearly allocate responsibility for device-related adverse events and study conduct issues. Insurance requirements must meet professional indemnity standards for clinical research. Patient consent and data protection clauses must ensure GDPR compliance and proper handling of sensitive health information throughout the study period.

Legal requirements in England and Wales

Your agreement must comply with the Medical Devices Regulations 2002 (as amended) and The Medical Devices (Amendment etc.) (EU Exit) Regulations 2019, ensuring MHRA approval procedures are followed. Good Clinical Practice (GCP) requirements under the Medicines for Human Use (Clinical Trials) Regulations 2004 must be incorporated, including proper training documentation and study monitoring procedures. Data protection obligations under UK GDPR and the Data Protection Act 2018 require specific clauses for data processing, storage, and international transfers. Ethics committee approval must be obtained in accordance with UK research governance frameworks, and the agreement should reference compliance with relevant NHS research governance arrangements. Professional standards from the General Medical Council and other healthcare bodies must be reflected in investigator qualification requirements. The agreement should also address compliance with the Health and Social Care Act 2012 and NHS Act 2006 when conducted within NHS facilities.